Spray drying of Norfenefrine-HCl is a process that converts a liquid solution into a dry, powdered form. Norfenefrine-HCl is a sympathomimetic drug used in the treatment of hypotension (low blood pressure). It works by stimulating alpha-adrenergic receptors, leading to an increase in peripheral vascular resistance and blood pressure. Spray drying can be used to improve the solubility and bioavailability of the drug by reducing particle size and increasing surface area. The resulting powder is easy to handle, store, and transport, and can be formulated into various dosage forms such as tablets, capsules, or injectables.
Spray-dried Norfenefrine-HCl has several applications in the pharmaceutical industry, including the development of sustained-release dosage forms, nasal sprays, and inhalation formulations. It is also used in the preparation of parenteral solutions and for the treatment of shock, heart failure, and other circulatory disorders. Spray drying technology provides a cost-effective and efficient method for producing high-quality Norfenefrine-HCl powder with enhanced physicochemical properties for various pharmaceutical applications.
Please see the application note for starting paramters, formulations and some results.